Durect’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

DURECT focused on the development of pharmaceutical products based on its drug delivery technology platforms.  Read more

James E Brown's photo - President & CEO of Durect

President & CEO

James E Brown

CEO Approval Rating

82/100

Founded:

1998

Status:

PublicNASDAQDRRX

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Recro Pharma is perceived as one of Durect's biggest rivals. Recro Pharma was founded in 2007, and is headquartered in Malvern, Pennsylvania. Like Durect, Recro Pharma also competes in the Pharmaceuticals space. Recro Pharma generates $43.7M more revenue vs. Durect.

Semnur Pharmaceuticals is a top competitor of Durect. Semnur Pharmaceuticals is a Private company that was founded in 2013 in Mountain View, California. Like Durect, Semnur Pharmaceuticals also works within the Pharmaceuticals sector. Compared to Durect, Semnur Pharmaceuticals has 60 fewer employees.

Innocoll is Durect's #3 rival. Innocoll is headquartered in Athlone, County Roscommon, and was founded in 1985. Innocoll operates in the Pharmaceuticals industry. Innocoll generates 8.79% the revenue of Durect.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Purdue a competitor of Durect?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$50.1M

Durect's revenue is the ranked 5th among it's top 10 competitors. The top 10 competitors average 530.2M. Over the last four quarters, Durect's revenue has grown by 140.1%. Specifically, in Q2 2020's revenue was $25.8M; in Q1 2020, it was $2.8M; in Q4 2019, it was $10.7M; in Q3 2019, Durect's revenue was $10.8M.

Acquisitions

No recent acquisitions found related to Durect

Durect Funding History

$84M

Since Durect was founded in 1998, it has participated in 1 round of funding. In total Durect has raised $84.0M. Durect's funding round was on Sep 2000 for a total of $84.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Sep 2000
$84M
-

Total Funding: $84M

Since Durect was founded in 1998, it has participated in 1 round of funding. In total Durect has raised $84.0M. Durect's funding round was on Sep 2000 for a total of $84.0M

Investments

No recent investments found related to Durect

Durect News

August 27, 2020MarketScreener

Announces Presentation of Phase 2a Pharmacokinetic Data of DUR-928 in Alcoholic Hepatitis at Digital International Liver Congress (EASL)

(marketscreener.com) CUPERTINO, Calif., Aug. 27, 2020 /PRNewswire/ -- DURECT Corporation today announ... See more »
August 26, 2020MarketScreener

Fireside Chat hosted by Ellie Merle of Cantor Fitzgerald

(marketscreener.com) CUPERTINO, Calif., Aug. 26, 2020 /PRNewswire/ -- DURECT Corporation announced to... See more »
August 5, 2020MarketScreener

to Present at the BTIG Biotechnology Conference 2020

(marketscreener.com) CUPERTINO, Calif., Aug. 5, 2020 /PRNewswire/ -- DURECT Corporation announced tod... See more »
July 3, 2020Pharmabiz

DURECT initiates phase 2 study of DUR928 to treat COVID19 patients with acute liver or kidney injury

DURECT Corporation, a biopharmaceutical company, announced it has initiated recruiting patients for i... See more »
June 29, 2020MarketScreener

Joins the Russell 3000 Index

(marketscreener.com) CUPERTINO, Calif., June 29, 2020 /PRNewswire/ -- DURECT Corporation today announ... See more »

Durect Press Releases

June 25, 2019PR Newswire

DURECT Receives Approval from Nasdaq for Transfer of Listing to Nasdaq Capital Market

CUPERTINO, Calif., June 25, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced th... See more »
May 16, 2019PR Newswire

DURECT to Present at the 20th Annual B. Riley FBR Institutional Investor Conference on May 22, 2019

CUPERTINO, Calif., May 16, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today tha... See more »
May 8, 2019CentralCharts

DURECT Corporation Announces Preliminary Data from the Ongoing DUR-928 Alcoholic Hepatitis Phase 2a Trial

CUPERTINO, Calif., May 7, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced prel... See more »
May 7, 2019StreetInsider

DURECT Corporation Announces First Quarter 2019 Financial Results and Update of Programs

DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended March ... See more »
May 7, 2019StreetInsider

DURECT Corporation Announces Preliminary Data from the Ongoing DUR-928 Alcoholic Hepatitis Phase 2a Trial

DURECT Corporation (Nasdaq: DRRX) today announced preliminary data from the ongoing DUR-928 alcoholic... See more »
May 7, 2019centralcharts

DURECT Corporation Announces First Quarter 2019 Financial Results and Update of Programs

CUPERTINO, Calif., May 7, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced fina... See more »
February 27, 2019PR Newswire

DURECT Announces Plans to Submit to FDA a Full Response to the POSIMIR® Complete Response Letter

CUPERTINO, Calif., Feb. 27, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced it... See more »

Headquarters

10260 Bubb Road

Cupertino, California95014

408-777-1417

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

DURECT focused on the development of pharmaceutical products based on its drug delivery technology platforms.  Durect was founded in 1998. Durect's headquarters is located in Cupertino, California, USA 95014. It has raised 84.0M in 1 round. The latest...

CEO

Durect's President & CEO, James E Brown, currently has an approval rating of 82%. Durect's primary competitors are Recro Pharma, Semnur Pharmaceuticals & Innocoll.

Website

durect.com

Frequently Asked Questions about Durect

  1. When was Durect founded?

    Durect was founded in 1998
  2. Who is Durect's CEO?

    Durect's CEO is James E Brown
  3. How much revenue does Durect generate?

    Durect generates $50.1M in revenue
  4. How much funding does Durect have?

    Durect has historically raised $84M in funding
  1. Where is Durect's headquarters?

    Durect's headquarters is in Cupertino California, USA
  2. How many employees does Durect have?

    Durect has 88 employees
  3. What sector does Durect operate in?

    Durect is in Pharmaceuticals, Biotechnology
  4. Who are Durect's competitors?

    Durect's top competitors are Recro Pharma, Semnur Pharmaceuticals, Innocoll